Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | GPCR |
---|---|---|
09:32 ET | 4480 | 38.875 |
09:34 ET | 1063 | 38.44 |
09:36 ET | 2956 | 38.15 |
09:38 ET | 1201 | 38.11 |
09:39 ET | 200 | 38.04 |
09:41 ET | 2764 | 37.99 |
09:43 ET | 1005 | 38.3 |
09:45 ET | 1236 | 38.4146 |
09:48 ET | 805 | 38.505 |
09:50 ET | 100 | 38.655 |
09:52 ET | 1300 | 38.565 |
09:54 ET | 100 | 38.555 |
09:56 ET | 100 | 38.53 |
09:57 ET | 3583 | 38.7 |
09:59 ET | 604 | 38.66 |
10:01 ET | 400 | 38.82 |
10:03 ET | 1798 | 38.905 |
10:06 ET | 1430 | 38.965 |
10:08 ET | 700 | 38.975 |
10:10 ET | 3050 | 38.9 |
10:12 ET | 1000 | 38.76 |
10:14 ET | 1700 | 38.745 |
10:15 ET | 2069 | 38.985 |
10:17 ET | 3679 | 39.22 |
10:19 ET | 14547 | 38.89 |
10:21 ET | 2346 | 38.77 |
10:24 ET | 2581 | 38.79 |
10:26 ET | 1825 | 38.825 |
10:28 ET | 4690 | 38.595 |
10:30 ET | 1781 | 38.4905 |
10:32 ET | 3261 | 38.46 |
10:33 ET | 1604 | 38.51 |
10:35 ET | 300 | 38.57 |
10:37 ET | 1221 | 38.535 |
10:39 ET | 1838 | 38.67 |
10:42 ET | 390 | 38.695 |
10:44 ET | 1450 | 38.62 |
10:46 ET | 2527 | 38.795 |
10:48 ET | 1575 | 38.78 |
10:50 ET | 100 | 38.78 |
10:51 ET | 1503 | 38.73 |
10:53 ET | 1770 | 38.62 |
10:55 ET | 900 | 38.565 |
10:57 ET | 100 | 38.59 |
11:00 ET | 1100 | 38.49 |
11:02 ET | 1500 | 38.39 |
11:04 ET | 484 | 38.335 |
11:06 ET | 607 | 38.26 |
11:08 ET | 1174 | 38.2624 |
11:09 ET | 4002 | 38.24 |
11:11 ET | 1760 | 38.28 |
11:13 ET | 800 | 38.26 |
11:15 ET | 435 | 38.28 |
11:18 ET | 2400 | 38.345 |
11:20 ET | 500 | 38.35 |
11:22 ET | 300 | 38.35 |
11:24 ET | 4313 | 38.485 |
11:26 ET | 637 | 38.47 |
11:29 ET | 1050 | 38.5 |
11:31 ET | 8535 | 38.365 |
11:33 ET | 2864 | 38.415 |
11:36 ET | 1000 | 38.41 |
11:38 ET | 2412 | 38.21 |
11:40 ET | 2751 | 37.9 |
11:42 ET | 700 | 37.91 |
11:44 ET | 3369 | 37.77 |
11:45 ET | 7377 | 37.915 |
11:47 ET | 779 | 37.965 |
11:49 ET | 2135 | 38.09 |
11:51 ET | 400 | 38.095 |
11:54 ET | 700 | 38.02 |
11:56 ET | 2617 | 37.945 |
11:58 ET | 2351 | 37.89 |
12:00 ET | 3879 | 37.96 |
12:02 ET | 4995 | 38.05 |
12:03 ET | 925 | 38.1 |
12:05 ET | 1955 | 38.01 |
12:07 ET | 1699 | 38.005 |
12:09 ET | 1000 | 38.1 |
12:12 ET | 1550 | 38.12 |
12:14 ET | 1000 | 38.14 |
12:16 ET | 1700 | 38.205 |
12:18 ET | 811 | 38.15 |
12:20 ET | 500 | 38.07 |
12:21 ET | 200 | 38.04 |
12:23 ET | 1028 | 37.92 |
12:25 ET | 1253 | 37.87 |
12:27 ET | 9838 | 38.01 |
12:30 ET | 2777 | 38 |
12:32 ET | 1662 | 38.13 |
12:34 ET | 1225 | 38.15 |
12:36 ET | 2398 | 38.065 |
12:38 ET | 3424 | 37.7 |
12:39 ET | 6326 | 37.855 |
12:41 ET | 1224 | 37.7 |
12:43 ET | 1865 | 37.62 |
12:45 ET | 5193 | 37.52 |
12:48 ET | 3022 | 37.49 |
12:50 ET | 1757 | 37.45 |
12:52 ET | 11492 | 37.445 |
12:54 ET | 2902 | 37.5075 |
12:56 ET | 6910 | 37.58 |
12:57 ET | 7348 | 37.6 |
12:59 ET | 14190 | 37.45 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Structure Therapeutics Inc | 2.1B | -16.1x | --- |
Apogee Therapeutics Inc | 2.2B | -18.3x | --- |
Iovance Biotherapeutics Inc | 2.1B | -4.1x | --- |
CG Oncology Inc | 2.1B | -27.4x | --- |
Janux Therapeutics Inc | 2.0B | -31.4x | --- |
Vera Therapeutics Inc | 1.9B | -17.1x | --- |
Structure Therapeutics Inc. is a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases. It is focused on G-protein coupled receptors (GPCRs) as a therapeutic target class. Its product candidates include GSBR-1290, Amylin, glucose-dependent insulinotropic polypeptide receptor (GIPR), GCGR, ANPA-0073 and LTSE-2578. It is developing GSBR-1290, its oral small molecule product candidate targeting the validated glucagon-like-peptide-1 receptor (GLP-1R) for the treatment of type 2 diabetes mellitus (T2DM) and obesity. It is developing GLP-1R candidates, including dual GLP-1R/GIPR agonists and amylin agonists, each designed with customized properties to achieve additional benefit. It is developing ANPA-0073, an investigational oral small molecule APJR agonist, for the treatment of idiopathic pulmonary fibrosis (IPF). It is evaluating its LPA1R program, LTSE-2578 for IPF and progressive pulmonary fibrosis.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.1B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 57.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.32 |
Book Value | $9.76 |
P/E Ratio | -16.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.